Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4370 results

Sort By:

Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR)

Study ID: NCT06234345
Start Date: 2026-09
End Date: 2028-08
Study Type

Interventional

Study Phase

Phase3

No. of Participants

1252

Intervention / Treatment

Fluticasone 250mcg/Formoterol 12mcg/Glycopyrronium 25mcg

COMPARATOR - TRIMBOW®

Sponsor

Eurofarma Laboratories S.A.

Source: clinicaltrials.gov

Share:
Add to list

Functional and Occupational Rehabilitation of Troops

Study ID: NCT06898866
Start Date: 2025-12
End Date: 2028-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

480

Intervention / Treatment
Sponsor

The University of Texas Health Science Center at San Antonio

Source: clinicaltrials.gov

Share:
Add to list

Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.

Study ID: NCT07107529
Start Date: 2025-10
End Date: 2034-02
Study Type

Interventional

Study Phase

Phase2

No. of Participants

150

Intervention / Treatment

Teclistamab

Talkqueamab

DARATUMUMAB

Sponsor

European Myeloma Network B.V.

Source: clinicaltrials.gov

Share:
Add to list

The Prevalence of Neck and Low Back Pain in FMSTRC Staff At the UWI Mona

Study ID: NCT07194746
Start Date: 2025-11-01
End Date: 2026-10-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Clinical Control Group (Group A)

Spine Exercise Program (Group B)

Sponsor

The University of The West Indies

Source: clinicaltrials.gov

Share:
Add to list

Poland Integrated Medicines Management (PL-IMM) - Study Assessing the Provision of Complex Clinical Pharmacy Services to Hospitalized Patients

Study ID: NCT07159932
Start Date: 2026-01-01
End Date: 2027-12-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

610

Intervention / Treatment

multidisciplinary treatment

Sponsor

Wroclaw Medical University

Source: clinicaltrials.gov

Share:
Add to list

Interactive Binocular Treatment (I- BiT) in Adult Patients With Anisometropic Amblyopia

Study ID: NCT07103473
Start Date: 2025-12-10
End Date: 2025-12-29
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

15

Intervention / Treatment

Interactive Binocular Treatment

Sponsor

Shahid Beheshti University of Medical Sciences

Source: clinicaltrials.gov

Share:
Add to list

Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy

Study ID: NCT06579469
Start Date: 2025-10
End Date: 2029-03
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment
Sponsor

St. Jude Children's Research Hospital

Source: clinicaltrials.gov

Share:
Add to list

Pathophysiological Study of the Sensitive Scalp

Study ID: NCT07156422
Start Date: 2025-10-01
End Date: 2026-10
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

A scalp biopsy using a 4 mm punch in the retroauricular hair zone

a general health questionnaire

Questionnaires concerning their sensitive scalp

Sponsor

University Hospital, Brest

Source: clinicaltrials.gov

Share:
Add to list

Intratumoral Injection of Standard Universal Donor Expanded Natural Killer Cells and TGF-beta Imprinted Natural Killer Cells for the Treatment of Skin Squamous Cell Carcinoma and Basal Cell Carcinoma

Study ID: NCT07144384
Start Date: 2025-10-01
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

40

Intervention / Treatment

Biopsy Procedure

Natural Killer Cell Therapy

Surgical Procedure

Universal Donor Expanded TGF-beta-imprinted NK Cells

Sponsor

Brittany Dulmage

Source: clinicaltrials.gov

Share:
Add to list

Department of Defense PTSD Adaptive Platform Trial - Intervention B - Vilazodone

Study ID: NCT05948579
Start Date: 2025-11
End Date: 2026-09
Study Type

Interventional

Study Phase

Phase2

No. of Participants

200

Intervention / Treatment

Intervention B Vilazodone Hydrochloride (HCl)

Intervention B Placebo

Sponsor

Global Coalition for Adaptive Research

Source: clinicaltrials.gov

Share:
Add to list